Status:
COMPLETED
Pharmacists Expand Access to Reproductive heaLthcare
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
Laura and John Arnold Foundation
Conditions:
Contraception
Eligibility:
FEMALE
18-51 years
Brief Summary
Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and u...
Detailed Description
Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. O...
Eligibility Criteria
Inclusion
- Women presenting to initiate hormonal contraception at a study pharmacy
Exclusion
- Pregnancy
- Contraindications to hormonal contraception
- Under 18 years of age
- Unable or unwilling to consent
Key Trial Info
Start Date :
January 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
471 Patients enrolled
Trial Details
Trial ID
NCT03830567
Start Date
January 27 2019
End Date
February 28 2022
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239